Selected article for: "activity analyze and acute respiratory syndrome"
Author: Heinen, Natalie; Meister, Toni Luise; Klöhn, Mara; Steinmann, Eike; Todt, Daniel; Pfaender, Stephanie
Title: Antiviral Effect of Budesonide against SARS-CoV-2
  • Cord-id: mrmvr0mr
  • Document date: 2021_7_20
    • ID: mrmvr0mr
    Snippet: Treatment options for COVID-19, a disease caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection, are currently severely limited. Therefore, antiviral drugs that efficiently reduce SARS-CoV-2 replication or alleviate COVID-19 symptoms are urgently needed. Inhaled glucocorticoids are currently being discussed in the context of treatment for COVID-19, partly based on a previous study that reported reduced recovery times in cases of mild COVID-19 after inhalative administr
    Document: Treatment options for COVID-19, a disease caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection, are currently severely limited. Therefore, antiviral drugs that efficiently reduce SARS-CoV-2 replication or alleviate COVID-19 symptoms are urgently needed. Inhaled glucocorticoids are currently being discussed in the context of treatment for COVID-19, partly based on a previous study that reported reduced recovery times in cases of mild COVID-19 after inhalative administration of the glucocorticoid budesonide. Given various reports that describe the potential antiviral activity of glucocorticoids against respiratory viruses, we aimed to analyze a potential antiviral activity of budesonide against SARS-CoV-2 and circulating variants of concern (VOC) B.1.1.7 (alpha) and B.1.351 (beta). We demonstrate a dose-dependent inhibition of SARS-CoV-2 that was comparable between all viral variants tested while cell viability remains unaffected. Our results are encouraging as they could indicate a multimodal mode of action of budesonide against SARS-CoV-2 and COVID-19, which could contribute to an improved clinical performance.

    Search related documents:
    Co phrase search for related documents
    • active compound and acute ards respiratory distress syndrome: 1, 2
    • active compound and acute respiratory: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
    • acute ards respiratory distress syndrome and low appear: 1
    • acute ards respiratory distress syndrome and low dosage: 1, 2
    • acute ards respiratory distress syndrome and lung mechanic: 1
    • acute respiratory and log logistic: 1, 2, 3, 4
    • acute respiratory and log logistic regression: 1, 2, 3, 4
    • acute respiratory and low appear: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • acute respiratory and low dosage: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • acute respiratory and lung mechanic: 1
    • acute respiratory and lung organoid: 1, 2